These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 32178672)
1. Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Hedayatnia M; Asadi Z; Zare-Feyzabadi R; Yaghooti-Khorasani M; Ghazizadeh H; Ghaffarian-Zirak R; Nosrati-Tirkani A; Mohammadi-Bajgiran M; Rohban M; Sadabadi F; Rahimi HR; Ghalandari M; Ghaffari MS; Yousefi A; Pouresmaeili E; Besharatlou MR; Moohebati M; Ferns GA; Esmaily H; Ghayour-Mobarhan M Lipids Health Dis; 2020 Mar; 19(1):42. PubMed ID: 32178672 [TBL] [Abstract][Full Text] [Related]
2. Association between obesity categories with cardiovascular disease and its related risk factors in the MASHAD cohort study population. Ghazizadeh H; Mirinezhad SMR; Asadi Z; Parizadeh SM; Zare-Feyzabadi R; Shabani N; Eidi M; Mosa Farkhany E; Esmaily H; Mahmoudi AA; Mouhebati M; Oladi MR; Rohban M; Sharifan P; Yadegari M; Saeidi F; Ferns GA; Ghayour-Mobarhan M J Clin Lab Anal; 2020 May; 34(5):e23160. PubMed ID: 31837061 [TBL] [Abstract][Full Text] [Related]
3. Six-year time-trend analysis of dyslipidemia among adults in Newfoundland and Labrador: findings from the laboratory information system between 2009 and 2014. Pedram P; Aref-Eshghi E; Mariathas HH; Hurley O; Godwin M; Duke P; Mahdavian M; Asghari S Lipids Health Dis; 2018 May; 17(1):99. PubMed ID: 29720176 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of combined and noncombined dyslipidemia in an Iranian population. Darroudi S; Saberi-Karimian M; Tayefi M; Arekhi S; Motamedzadeh Torghabeh A; Seyedzadeh Sani SMR; Moohebati M; Heidari-Bakavoli A; Ebrahimi M; Azarpajouh MR; Safarian M; A Ferns G; Esmaeili H; Parizadeh MR; Mokhber N; Mahdizadeh A; Mahmoudi AA; Sahebkar AH; Ghayour-Mobarhan M J Clin Lab Anal; 2018 Oct; 32(8):e22579. PubMed ID: 29926995 [TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012). Georgoulis M; Chrysohoou C; Georgousopoulou E; Damigou E; Skoumas I; Pitsavos C; Panagiotakos D Lipids Health Dis; 2022 Dec; 21(1):141. PubMed ID: 36529737 [TBL] [Abstract][Full Text] [Related]
6. Lipid Profile and Subsequent Cardiovascular Disease among Young Adults Aged < 50 Years. Kaneko H; Itoh H; Kiriyama H; Kamon T; Fujiu K; Morita K; Michihata N; Jo T; Takeda N; Morita H; Yasunaga H; Komuro I Am J Cardiol; 2021 Mar; 142():59-65. PubMed ID: 33301771 [TBL] [Abstract][Full Text] [Related]
7. Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China. Li X; Gao L; Wang Z; Guan B; Guan X; Wang B; Han X; Xiao X; Waleed KB; Chandran C; Wu S; Xia Y Clin Cardiol; 2018 Mar; 41(3):314-320. PubMed ID: 29575115 [TBL] [Abstract][Full Text] [Related]
8. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study. Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203 [TBL] [Abstract][Full Text] [Related]
9. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease. Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248 [TBL] [Abstract][Full Text] [Related]
10. The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China. Ge P; Dong C; Ren X; Weiderpass E; Zhang C; Fan H; Zhang J; Zhang Y; Xi J PLoS One; 2015; 10(12):e0144104. PubMed ID: 26640891 [TBL] [Abstract][Full Text] [Related]
11. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010. Wong ND; Chuang J; Zhao Y; Rosenblit PD J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670 [TBL] [Abstract][Full Text] [Related]
12. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study. Kaze AD; Santhanam P; Musani SK; Ahima R; Echouffo-Tcheugui JB J Am Heart Assoc; 2021 Apr; 10(7):e016947. PubMed ID: 33728932 [TBL] [Abstract][Full Text] [Related]
13. Variability in lipid profile among patients presented with acute myocardial infarction, unstable angina and stable angina pectoris. Yang N; Feng JP; Chen G; Kou L; Li Y; Ren P; Zhao LL; Qin Q Eur Rev Med Pharmacol Sci; 2014; 18(24):3761-6. PubMed ID: 25555864 [TBL] [Abstract][Full Text] [Related]
14. [Associations between 4 lipid biomarkers and cardiometabolic multimorbidity development in middle aged and old adults in China]. Jin YC; Cheng YY; Zhou YG; Zhang Y; Wang H; Xu XL Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Jul; 45(7):923-931. PubMed ID: 39004963 [No Abstract] [Full Text] [Related]
15. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910 [TBL] [Abstract][Full Text] [Related]
16. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study. Lee JS; Chang PY; Zhang Y; Kizer JR; Best LG; Howard BV Diabetes Care; 2017 Apr; 40(4):529-537. PubMed ID: 28122840 [TBL] [Abstract][Full Text] [Related]
17. Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults-Sri Lanka Diabetes and Cardiovascular Study in 2005-2006. Katulanda P; Dissanayake HA; De Silva SDN; Katulanda GW; Liyanage IK; Constantine GR; Sheriff R; Matthews DR J Clin Lipidol; 2018; 12(2):447-454. PubMed ID: 29429894 [TBL] [Abstract][Full Text] [Related]
18. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study. Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651 [TBL] [Abstract][Full Text] [Related]
19. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study. Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384 [TBL] [Abstract][Full Text] [Related]
20. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study. Al-Shamsi S; Regmi D; Govender RD BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]